Otto Aline P, França Marcela M, Correa Fernanda A, Costalonga Everlayny F, Leite Claudia C, Mendonca Berenice B, Arnhold Ivo J P, Carvalho Luciani R S, Jorge Alexander A L
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42 do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HC da FMUSP), Disciplina de Endocrinologia, Universidade de Sao Paulo, São Paulo, 05403-900, Brazil.
Pituitary. 2015 Aug;18(4):561-7. doi: 10.1007/s11102-014-0610-9.
Children initially diagnosed with isolated GH deficiency (IGHD) have a variable rate to progress to combined pituitary hormone deficiency (CPHD) during follow-up.
To evaluate the development of CPHD in a group of childhood-onset IGHD followed at a single tertiary center over a long period of time.
We retrospectively analyzed data from 83 patients initially diagnosed as IGHD with a mean follow-up of 15.2 years. The Kaplan-Meier method and Cox regression analysis was used to estimate the temporal progression and to identify risk factors to development of CPHD over time.
From 83 patients initially with IGHD, 37 (45%) developed CPHD after a median time of follow up of 5.4 years (range from 1.2 to 21 years). LH and FSH deficiencies were the most common pituitary hormone (38%) deficiencies developed followed by TSH (31%), ACTH (12%) and ADH deficiency (5%). ADH deficiency (3.1 ± 1 years from GHD diagnosis) presented earlier and ACTH deficiency (9.3 ± 3.5 years) presented later during follow up compared to LH/FSH (8.3 ± 4 years) and TSH (7.5 ± 5.6 years) deficiencies. In a Cox regression model, pituitary stalk abnormalities was the strongest risk factor for the development of CPHD (hazard ratio of 3.28; p = 0.002).
Our study indicated a high frequency of development of CPHD in patients initially diagnosed as IGHD at childhood. Half of our patients with IGHD developed the second hormone deficiency after 5 years of diagnosis, reinforcing the need for lifelong monitoring of pituitary function in these patients.
最初被诊断为孤立性生长激素缺乏症(IGHD)的儿童在随访期间进展为垂体联合激素缺乏症(CPHD)的发生率各不相同。
评估在一家单一的三级中心长期随访的一组儿童期起病的IGHD患者中CPHD的发生情况。
我们回顾性分析了83例最初被诊断为IGHD患者的数据,平均随访时间为15.2年。采用Kaplan-Meier法和Cox回归分析来估计随时间的进展情况,并确定CPHD发生的危险因素。
83例最初患有IGHD的患者中,37例(45%)在中位随访时间5.4年(范围为1.2至21年)后发生了CPHD。促黄体生成素(LH)和促卵泡生成素(FSH)缺乏是最常见的垂体激素缺乏(38%),其次是促甲状腺激素(TSH)缺乏(31%)、促肾上腺皮质激素(ACTH)缺乏(12%)和抗利尿激素(ADH)缺乏(5%)。与LH/FSH缺乏(8.3±4年)和TSH缺乏(7.5±5.6年)相比,ADH缺乏在随访期间出现较早(从生长激素缺乏症诊断起3.1±1年),ACTH缺乏出现较晚(9.3±3.5年)。在Cox回归模型中,垂体柄异常是CPHD发生的最强危险因素(风险比为3.28;p=0.002)。
我们的研究表明,最初在儿童期被诊断为IGHD的患者中CPHD的发生率很高。我们一半的IGHD患者在诊断5年后出现了第二种激素缺乏,这进一步强调了对这些患者进行垂体功能终身监测的必要性。